Impact of E-Cigarette Regulation on Smoking Rates: Analysis of 6 Jurisdictions

Nov.30.2022
Impact of E-Cigarette Regulation on Smoking Rates: Analysis of 6 Jurisdictions
This study analyzes the impact of e-cigarette regulations on smoking rates in six jurisdictions, finding varied results.

The research titled "The Impact of E-Cigarette Introduction on Smoking in Six Jurisdictions with Different Electronic Cigarette Regulatory Methods: Interrupted Time Series Analysis" analyzed smoking rates and cigarette consumption in six jurisdictions with different regulatory environments for electronic cigarettes. These jurisdictions include Alberta, Ontario, Quebec, and British Columbia (in Canada), the United Kingdom, and Australia.


Australia has the most stringent regulations on electronic cigarettes among these countries, which translates to the lowest usage rate. However, when it comes to reducing smoking rates, it is also one of the countries making the least progress.


According to Dr Colin Mendelsohn, an expert in tobacco treatment, in a blog post, this study demonstrates once again that the prevalence of electronic cigarettes in Canada and the UK has resulted in a faster decline in smoking rates and the amount of smoking among young people.


However, in Australia, the rate of decrease in tobacco consumption among adult smokers has slowed, and with the rise in popularity of e-cigarettes, the rate of decline in smoking among young people has also slowed.


Australia has implemented the strictest regulations on e-cigarettes in the Western world due to concerns that these devices may lead young people who otherwise would not smoke to start smoking. However, some argue that these regulations are misguided, as they also limit access to potentially life-saving alternatives for adult smokers and could contribute to more smoking-related deaths and illnesses. Mendelsohn adds that this is a pressing issue that needs to be addressed.


Effectiveness of E-Cigarettes for Smoking Cessation


A study published in the Addiction journal in 2019 and based on global data has confirmed that electronic cigarettes help smokers in Australia quit smoking. Titled "The impact of electronic cigarettes on successful smoking cessation in Australia in 2019: Evidence from a national survey," the study involved 1,601 smokers and found that the probability of successfully quitting smoking increased by 68%-124% when using electronic cigarettes compared to those who did not use them, further proving their effectiveness in helping smokers quit.


Interestingly, the best results are seen amongst electronic cigarette users who obtain their e-liquid from foreign websites. Another strange finding shows that using a smartphone application in conjunction with an electronic cigarette increases the chances of quitting smoking by 74%, compared to not using an application.


2FIRSTS will continue to provide updates on this topic, and future content will be posted on the "2FIRSTSAPP". Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
British American Tobacco (BAT) subsidiary Vuse Alto has recently adjusted its price tiers in U.S. convenience store channels, leveraging low-cost device kits and pod promotions to reinforce its positioning in the mid-priced closed-system e-cigarette market.
Jun.17
Moscow Police Seize About 65,000 E-Cigarettes Worth More Than RUB 30 Million
Moscow Police Seize About 65,000 E-Cigarettes Worth More Than RUB 30 Million
Russian Interior Ministry spokesperson Irina Volk said on May 6 that police in Moscow seized about 65,000 nicotine-containing products from a man during searches of residential and warehouse premises. The products were valued at about RUB 30 million, or about USD 395,727 based on an exchange rate of USD 1 = RUB 75.81.
May.11 by 2FIRSTS.ai
Product | KT&G Expands lil AIBLE 3.0 Sales to Seoul Convenience Stores, Launches Two New AIIM Variants
Product | KT&G Expands lil AIBLE 3.0 Sales to Seoul Convenience Stores, Launches Two New AIIM Variants
According to South Korean media reports, KT&G has expanded sales of its heated tobacco device lil AIBLE 3.0 to convenience stores across Seoul starting May 13. The convenience-store version is offered in the exclusive OUD GRAY color. On the same day, KT&G also launched two new dedicated consumables for the lil AIBLE platform—AIIM REMIX and AIIM ICESPOT—at convenience stores nationwide, each priced at KRW 4,800.
Market
Jun.01
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18